| pubmed-article:11269740 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0012920 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0146224 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C1709518 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:11269740 | lifeskim:mentions | umls-concept:C1705294 | lld:lifeskim |
| pubmed-article:11269740 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11269740 | pubmed:dateCreated | 2001-3-27 | lld:pubmed |
| pubmed-article:11269740 | pubmed:abstractText | In vitro and in vivo preclinical models have demonstrated synergistic activity when topoisomerase I and II inhibitors are administered sequentially. Topoisomerase I inhibitors increase topoisomerase II levels and increase cell kill induced by topoisomerase II poisons. We evaluated this hypothesis in a cohort of patients with advanced non-small-cell lung cancer (NSCLC). | lld:pubmed |
| pubmed-article:11269740 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11269740 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11269740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11269740 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11269740 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:BergerS JSJ | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:HoppelC LCL | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:BergerN ANA | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:GordonN HNH | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:RemickS CSC | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:LevitasAA | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:DowlatiAA | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:IngallsS TST | lld:pubmed |
| pubmed-article:11269740 | pubmed:author | pubmed-author:GoskyD MDM | lld:pubmed |
| pubmed-article:11269740 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11269740 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:11269740 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11269740 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11269740 | pubmed:pagination | 141-8 | lld:pubmed |
| pubmed-article:11269740 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:meshHeading | pubmed-meshheading:11269740... | lld:pubmed |
| pubmed-article:11269740 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11269740 | pubmed:articleTitle | Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer. | lld:pubmed |
| pubmed-article:11269740 | pubmed:affiliation | Division of Hematology/Oncology, Case Western Reserve University and University Hospitals of Cleveland, Ohio 44106, USA. axd44@po.cwru.edu | lld:pubmed |
| pubmed-article:11269740 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11269740 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11269740 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11269740 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11269740 | lld:pubmed |
